CTLA4 and neoplasm: In contrast to this, capecitabine was found to inhibit the expression of CTLA-4 in colorectal cancer cells [279], and the anti-tumor activity of orlistat, an FASN inhibitor, has been associated with the reduction of PD-L1 expression [280].